Page 1

Studies in voorbereiding – Afdeling Hematologie

Externe code

Titel

Onderzoeker

Start

A prospective non-interventional post-authorization safety study CC-5013-MDS010

(PASS), designed as a disease registry of patients with transfusion

Langemeijer, S.M.C.

-

Stevens, W.B.C.

-

Spronsen, van D.J.

-

Croockewit, A.J.

-

Schaap, N.P.M.

-

Schaap, N.P.M.

-

Blijlevens, N.M.A.

-

Evers, D.

-

Laros, B.A.P.

-

dependent IPSS low or intermediate-1-risk myelodysplastic syndromes (MDS) and isolated del(5q) Phase I-II study combining brentuximab vedotin with second line salvage chemotherapy (R-DHAP) in CD30 positive diffuse large

HOVON136

B-cell lymphoma patients refractory to first line chemotherapy or in first relapse who are eligible for high dose treatment followed by autologous stem cell transplantation

Biobank B-cel

Pathogenese en therapie respons van B-cel maligniteiten

maligniteiten

NIVO/DARA

A phase 2 study of nivolumab combined with daratumumab with or without low-dose cyclophosphamide in relapsed/refractory multiple myeloma An international multi-centric observational study on the use of

CINC424BIC04

ruxolitinib in the treatment of patients with polycythemia vera resistant or intolerant to hydroxyurea

GS-US-3524365

Extended Access of Momelotinib for Subjects with Primary Myelofibrosis (PMF) or Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis (Post-PV/ET MF) A first-in-patient, multi-center, double-blind, placebo controlled, ascending dose, randomized phase 1B/2A study, investigating the safety, tolerability, pharmacokinetics and

GLY-211-2017

pharmacodynamics of subcutaneous administration of the GLP2 receptor agonist FE 203799 in adults with lymphomas, undergoing myeloablative conditioning chemotherapy followed by autologous hematopoietic stem cell transplantation The BITE study: a nationwide epidemiological and laboratory

BITE

case cohort study investigating risk factors for bleeding in hemato-oncology patients

SLIM

Shared medical appointments to change lifestyles of overweight hemophilia patients

Studies in voorbereiding – Afdeling Hematologie – Radboudumc Juni 2018

1


Obizur EU

Prospective, non-interventional study to evaluate the safety and

PASS

effectiveness of Obizur in real-life practice

DYNAMO

HIN-6

The Dynamic interplay between bleeding phenotype and baseline factor level in moderate and mild hemophilia A and B Haemophilia in the Netherlands 6

Schols, S.E.M.

-

Brons, P.P.T.

-

Schols, S.E.M.

07 - 2018

Indien u nadere informatie wenst over een studie van afdeling Hematologie, dan kunt u contact opnemen met het Trialbureau Hematologie, bereikbaar via telefoonnummer 024 – 3614794 en/of e-mail trialbureauhemat-onco@radboudumc.nl.

Studies in voorbereiding – Afdeling Hematologie – Radboudumc Juni 2018

2

Hemat studies in voorbereiding 03 2017  
Hemat studies in voorbereiding 03 2017